<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39014958</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study.</ArticleTitle><Pagination><StartPage>e29800</StartPage><MedlinePgn>e29800</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29800</ELocationID><Abstract><AbstractText>Globally, the rollout of COVID-19 vaccine had been faced with a significant barrier in the form of vaccine hesitancy. This study adopts a multi-stage perspective to explore the prevalence and determinants of COVID-19 vaccine hesitancy, focusing on their dynamic evolutionary features. Guided by the integrated framework of the 3Cs model (complacency, confidence, and convenience) and the EAH model (environmental, agent, and host), this study conducted three repeated national cross-sectional surveys. These surveys carried out from July 2021 to February 2023 across mainland China, targeted individuals aged 18 and older. They were strategically timed to coincide with three critical vaccination phases: universal coverage (stage 1), partial coverage (stage 2), and key population coverage (stage 3). From 2021 to 2023, the surveys examined sample sizes of 29&#x2009;925, 6659, and 5407, respectively. The COVID-19 vaccine hesitation rates increased from 8.39% in 2021 to 29.72% in 2023. Urban residency, chronic condition, and low trust in vaccine developer contributed to significant COVID-19 vaccine hesitancy across the pandemic. Negative correlations between the intensity of vaccination policies and vaccine hesitancy, and positive correlations between vaccine hesitancy and long COVID, were confirmed. This study provides insights for designing future effective vaccination programs for emerging vaccine-preventable infectious X diseases.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Zhanlei</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-7654-7243</Identifier><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Quanman</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Dongfang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Junwen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Ruizhe</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingbao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meiyun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Jianqin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Southern University of Science and Technology, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yinfei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Wenyong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haipeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, School of Public Health, Hangzhou Normal University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health, Fudan University, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Health Management, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Global Health, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarimo</LastName><ForeName>Clifford Silver</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Mingze</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Yudong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henan Province Engineering Research Center of Health Economy &amp; Health Technology Assessment, Zhengzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>National Social Science Fund of China</Agency><Country/></Grant><Grant><Agency>Collaborative Innovation Key Project of Zhengzhou</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="Y">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19 vaccination</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">dynamic evolution</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39014958</ArticleId><ArticleId IdType="doi">10.1002/jmv.29800</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS&#x2010;CoV&#x2010;2 and COVID&#x2010;19. Nat Rev Microbiol. 2021;19(3):141&#x2010;154. doi:10.1038/s41579-020-00459-7</Citation></Reference><Reference><Citation>The Lancet Neurology. The neurological impact of COVID&#x2010;19. Lancet Neurol. 2020;19(6):471. doi:10.1016/S1474-4422(20)30142-3</Citation></Reference><Reference><Citation>Politi J, Mart&#xed;n&#x2010;S&#xe1;nchez M, Mercuriali L, et al. Epidemiological characteristics and outcomes of COVID&#x2010;19 cases: mortality inequalities by socio&#x2010;economic status, Barcelona, Spain, 24 February to 4 May 2020. Euro Surveill. 2021;26(20):2001138. doi:10.2807/1560-7917.ES.2021.26.20.2001138</Citation></Reference><Reference><Citation>Coping with COVID. Nature Immunol. 2021;22(3):255. doi:10.1038/s41590-021-00900-w</Citation></Reference><Reference><Citation>Wasserman D, Iosue M, Wuestefeld A, Carli V. Adaptation of evidence&#x2010;based suicide prevention strategies during and after the COVID &#x2010;19 pandemic. World Psychiatry. 2020;19(3):294&#x2010;306. doi:10.1002/wps.20801</Citation></Reference><Reference><Citation>WHO. Statement on the fifteenth meeting of the IHR. Emergency Committee on the COVID&#x2010;19 pandemic. 2005. Accessed December 10, 2023. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</Citation></Reference><Reference><Citation>Ikilezi G, Micah AE, Bachmeier SD, et al. Estimating total spending by source of funding on routine and supplementary immunisation activities in low&#x2010;income and middle&#x2010;income countries, 2000&#x2013;17: a financial modelling study. Lancet. 2021;398(10314):1875&#x2010;1893. doi:10.1016/S0140-6736(21)01591-9</Citation></Reference><Reference><Citation>Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID&#x2010;19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615&#x2010;632. doi:10.1038/s41577-020-00434-6</Citation></Reference><Reference><Citation>Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID&#x2010;19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626&#x2010;636. doi:10.1038/s41577-021-00592-1</Citation></Reference><Reference><Citation>MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161&#x2010;4164. doi:10.1016/j.vaccine.2015.04.036</Citation></Reference><Reference><Citation>Sol&#xed;s Arce JS, Warren SS, Meriggi NF, et al. COVID&#x2010;19 vaccine acceptance and hesitancy in low&#x2010; and middle&#x2010;income countries. Nature Med. 2021;27(8):1385&#x2010;1394. doi:10.1038/s41591-021-01454-y</Citation></Reference><Reference><Citation>Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID&#x2010;19 vaccine hesitancy in a representative working&#x2010;age population in France: a survey experiment based on vaccine characteristics. Lancet Pub Health. 2021;6(4):e210&#x2010;e221. doi:10.1016/S2468-2667(21)00012-8</Citation></Reference><Reference><Citation>Lazarus JV, Wyka K, White TM, et al. A survey of COVID&#x2010;19 vaccine acceptance across 23 countries in 2022. Nature Med. 2023;29(2):366&#x2010;375. doi:10.1038/s41591-022-02185-4</Citation></Reference><Reference><Citation>Freeman D, Loe BS, Yu LM, et al. Effects of different types of written vaccination information on COVID&#x2010;19 vaccine hesitancy in the UK (OCEANS&#x2010;III): a single&#x2010;blind, parallel&#x2010;group, randomised controlled trial. Lancet Pub Health. 2021;6(6):e416&#x2010;e427. doi:10.1016/S2468-2667(21)00096-7</Citation></Reference><Reference><Citation>Wu J, Li Q, Silver Tarimo C, et al. COVID&#x2010;19 vaccine hesitancy among Chinese population: a large&#x2010;scale national study. Front Immunol. 2021;12:781161. doi:10.3389/fimmu.2021.781161</Citation></Reference><Reference><Citation>Mallapaty S. Researchers fear growing COVID vaccine hesitancy in developing nations. Nature. 2022;601(7892):174&#x2010;175. doi:10.1038/d41586-021-03830-7</Citation></Reference><Reference><Citation>Otu A, Osifo&#x2010;Dawodu E, Atuhebwe P, Agogo E, Ebenso B. Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID&#x2010;19 vaccine nationalism. Lancet Microbe. 2021;2(8):e347&#x2010;e348. doi:10.1016/S2666-5247(21)00126-9</Citation></Reference><Reference><Citation>Dhalaria P, Arora H, Singh AK, Mathur M, S. AK. COVID&#x2010;19 vaccine hesitancy and vaccination coverage in India: an exploratory analysis. Vaccines. 2022;10(5):739. doi:10.3390/vaccines10050739</Citation></Reference><Reference><Citation>Chen L, Li Z, Lu X, et al. Changes in COVID&#x2010;19 vaccine hesitancy at different times among residents in Guangzhou, China. Front Public Health. 2023;11:1164475. doi:10.3389/fpubh.2023.1164475</Citation></Reference><Reference><Citation>Xiao J, Cheung JK, Wu P, Ni MY, Cowling BJ, Liao Q. Temporal changes in factors associated with COVID&#x2010;19 vaccine hesitancy and uptake among adults in Hong Kong: serial cross&#x2010;sectional surveys. Lancet Region Health Western Pacific. 2022;23:100441. doi:10.1016/j.lanwpc.2022.100441</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2010;146. doi:10.1038/s41579-022-00846-2</Citation></Reference><Reference><Citation>Machingaidze S, Wiysonge CS. Understanding COVID&#x2010;19 vaccine hesitancy. Nature Med. 2021;27(8):1338&#x2010;1339. doi:10.1038/s41591-021-01459-7</Citation></Reference><Reference><Citation>Al&#x2010;Mohaithef M, Padhi BK. Determinants of COVID&#x2010;19 vaccine acceptance in Saudi Arabia: a web&#x2010;based national survey. J Multidiscip Healthc. 2020;13:1657&#x2010;1663. doi:10.2147/JMDH.S276771</Citation></Reference><Reference><Citation>Wang G, Yao Y, Wang Y, et al. Determinants of COVID&#x2010;19 vaccination status and hesitancy among older adults in China. Nature Med. 2023;29(3):623&#x2010;631. doi:10.1038/s41591-023-02241-7</Citation></Reference><Reference><Citation>Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID&#x2010;19 vaccine acceptance in the US. eClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495</Citation></Reference><Reference><Citation>Wang J, Ji Q, Dong S, et al. Factors influencing vaccine hesitancy in China: a qualitative study. Vaccines. 2021;9(11):1291. doi:10.3390/vaccines9111291</Citation></Reference><Reference><Citation>Ghaznavi C, Yoneoka D, Kawashima T, et al. Factors associated with reversals of COVID&#x2010;19 vaccination willingness: results from two longitudinal, national surveys in Japan 2021&#x2013;2022. The Lancet Region Health Western Pacific. 2022;27:100540. doi:10.1016/j.lanwpc.2022.100540</Citation></Reference><Reference><Citation>Ding D, Zhang R. China's COVID&#x2010;19 control strategy and its impact on the global pandemic. Front Public Health. 2022;10:857003. doi:10.3389/fpubh.2022.857003</Citation></Reference><Reference><Citation>Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523. doi:10.1016/j.socscimed.2021.114523</Citation></Reference><Reference><Citation>Wu J, Ma M, Li Q, et al. Dynamic trends and underlying factors of COVID&#x2010;19 vaccine booster hesitancy in adults: cross&#x2010;sectional observational study. JMIR Public Health Surveill. 2023;9(1):e44822. doi:10.2196/44822</Citation></Reference><Reference><Citation>Hale T, Angrist N, Goldszmidt R, et al. A global panel database of pandemic policies (Oxford COVID&#x2010;19 Government Response Tracker). Nature Human Behav. 2021;5(4):529&#x2010;538. doi:10.1038/s41562-021-01079-8</Citation></Reference><Reference><Citation>D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non&#x2010;randomized control group. Stat Med. 1998;17(19):2265&#x2010;2281. doi:10.1002/(SICI)1097-0258(19981015)17:19&lt;2265::AID-SIM918&gt;3.0.CO;2-B</Citation></Reference><Reference><Citation>Huang Y, Su X, Xiao W, et al. COVID&#x2010;19 vaccine hesitancy among different population groups in China: a national multicenter online survey. BMC Infect Dis. 2022;22(1):153. doi:10.1186/s12879-022-07111-0</Citation></Reference><Reference><Citation>Lazarus JV, Wyka K, White TM, et al. Revisiting COVID&#x2010;19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun. 2022;13(1):3801. doi:10.1038/s41467-022-31441-x</Citation></Reference><Reference><Citation>Siu JY. Health inequality experienced by the socially disadvantaged populations during the outbreak of COVID&#x2010;19 in Hong Kong: an interaction with social inequality. Health Soc Care Commun. 2021;29(5):1522&#x2010;1529. doi:10.1111/hsc.13214</Citation></Reference><Reference><Citation>Saelee R, Zell E, Murthy BP, et al. Disparities in COVID&#x2010;19 vaccination coverage between urban and rural counties&#x2014;United States, December 14, 2020&#x2013;January 31, 2022. Morb Mortal Wkly Rep. 2022;71(9):335&#x2010;340. doi:10.15585/mmwr.mm7109a2</Citation></Reference><Reference><Citation>Murphy J, Valli&#xe8;res F, Bentall RP, et al. Psychological characteristics associated with COVID&#x2010;19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):29. doi:10.1038/s41467-020-20226-9</Citation></Reference><Reference><Citation>Jin S, Lin L, Larson HJ, Cook AR. COVID&#x2010;19 vaccine acceptance and its associated factors in the Western pacific region. Lancet Region Health Western Pacific. 2024;43:100840. doi:10.1016/j.lanwpc.2023.100840</Citation></Reference><Reference><Citation>Talic S, Shah S, Wild H, et al. Effectiveness of public health measures in reducing the incidence of covid&#x2010;19, SARS&#x2010;CoV&#x2010;2 transmission, and covid&#x2010;19 mortality: systematic review and meta&#x2010;analysis. BMJ. 2021;17(375):e068302. doi:10.1136/bmj-2021-068302</Citation></Reference><Reference><Citation>Hussain B, Latif A, Timmons S, Nkhoma K, Nellums LB. Overcoming COVID&#x2010;19 vaccine hesitancy among ethnic minorities: a systematic review of UK studies. Vaccine. 2022;40(25):3413&#x2010;3432. doi:10.1016/j.vaccine.2022.04.030</Citation></Reference><Reference><Citation>Yang C, Lapp L, Tebbutt SJ. Overcoming COVID&#x2010;19 vaccine hesitancy hurdles. Lancet. 2023;402(10408):1129&#x2010;1130. doi:10.1016/S0140-6736(23)01425-3</Citation></Reference><Reference><Citation>Wu J, Shen Z, Li Q, et al. How urban versus rural residency relates to COVID&#x2010;19 vaccine hesitancy: a large&#x2010;scale national Chinese study. Soc Sci Med. 2023;320:115695. doi:10.1016/j.socscimed.2023.115695</Citation></Reference><Reference><Citation>Yoda T, Katsuyama H. Willingness to receive COVID&#x2010;19 vaccination in Japan. Vaccines. 2021;9(1):48. doi:10.3390/vaccines9010048</Citation></Reference><Reference><Citation>Alam W, Manzoor F, Farnaz N, Aktar B, Rashid SF. Perception and attitudes towards COVID&#x2010;19 vaccination among urban slum dwellers in Dhaka, Bangladesh. Lancet Global Health. 2022;10:S3. doi:10.1016/S2214-109X(22)00132-2</Citation></Reference><Reference><Citation>Acar&#x2010;Burkay S, Cristian DC. Cognitive underpinnings of COVID&#x2010;19 vaccine hesitancy. Soc Sci Med. 2022;301:114911. doi:10.1016/j.socscimed.2022.114911</Citation></Reference><Reference><Citation>Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID&#x2010;19 infection? Lancet Respir Med. 2020;8(4):e21. doi:10.1016/S2213-2600(20)30116-8</Citation></Reference><Reference><Citation>Omer SB, Benjamin RM, Brewer NT, et al. Promoting COVID&#x2010;19 vaccine acceptance: recommendations from the lancet commission on vaccine refusal, acceptance, and demand in the USA. Lancet. 2021;398(10317):2186&#x2010;2192. doi:10.1016/S0140-6736(21)02507-1</Citation></Reference><Reference><Citation>Song J, Park J, Lee J, et al. National prevalence and determinants of COVID&#x2010;19 vaccine hesitancy during the initial phase pandemic. Eur Rev Med Pharmacol Sci. 2023;27(17):8280&#x2010;8290. doi:10.26355/eurrev_202309_33588</Citation></Reference><Reference><Citation>Milo&#x161;evi&#x107; &#x110;or&#x111;evi&#x107; J, Mari S, Vdovi&#x107; M, Milo&#x161;evi&#x107; A. Links between conspiracy beliefs, vaccine knowledge, and trust: anti&#x2010;vaccine behavior of Serbian adults. Soc Sci Med. 2021;277:113930. doi:10.1016/j.socscimed.2021.113930</Citation></Reference><Reference><Citation>Wong ICK, Wan EYF, Chui CSL, Li X, Chan EWY. Adverse event reporting and Bell's palsy risk after COVID&#x2010;19 vaccination&#x2014;authors' reply. Lancet Infect Dis. 2021;21(11):1492&#x2010;1493. doi:10.1016/S1473-3099(21)00631-9</Citation></Reference><Reference><Citation>Du F, Chantler T, Francis MR, et al. The determinants of vaccine hesitancy in China: a cross&#x2010;sectional study following the Changchun Changsheng vaccine incident. Vaccine. 2020;38(47):7464&#x2010;7471. doi:10.1016/j.vaccine.2020.09.075</Citation></Reference><Reference><Citation>Flor LS, Friedman J, Spencer CN, et al. Quantifying the effects of the COVID&#x2010;19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021. Lancet. 2022;399(10344):2381&#x2010;2397. doi:10.1016/S0140-6736(22)00008-3</Citation></Reference><Reference><Citation>Kan T, Zhang J. Factors influencing seasonal influenza vaccination behaviour among elderly people: a systematic review. Pub Health. 2018;156:67&#x2010;78. doi:10.1016/j.puhe.2017.12.007</Citation></Reference><Reference><Citation>Lu Q, Zhang Y, Geng T, et al. Association of lifestyle factors and antihypertensive medication use with risk of all&#x2010;cause and cause&#x2010;specific mortality among adults with hypertension in China. JAMA Network Open. 2022;5(2):e2146118. doi:10.1001/jamanetworkopen.2021.46118</Citation></Reference><Reference><Citation>Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA&#x2010;1273 SARS&#x2010;CoV&#x2010;2 vaccine. N Engl J Med. 2021;384(5):403&#x2010;416. doi:10.1056/NEJMoa2035389</Citation></Reference><Reference><Citation>Aknin LB, Andretti B, Goldszmidt R, et al. Policy stringency and mental health during the COVID&#x2010;19 pandemic: a longitudinal analysis of data from 15 countries. Lancet Pub Health. 2022;7(5):e417&#x2010;e426. doi:10.1016/S2468-2667(22)00060-3</Citation></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, Aerts JG, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID&#x2010;19 in 2020 and 2021. JAMA. 2022;328(16):1604. doi:10.1001/jama.2022.18931</Citation></Reference><Reference><Citation>Binagwaho A, Mathewos K, Davis S. Time for the ethical management of COVID&#x2010;19 vaccines. Lancet Global Health. 2021;9(8):e1169&#x2010;e1171. doi:10.1016/S2214-109X(21)00180-7</Citation></Reference><Reference><Citation>Mohamed K, Rzymski P, Islam MS, et al. COVID&#x2010;19 vaccinations: the unknowns, challenges, and hopes. J Med Virol. 2022;94(4):1336&#x2010;1349. doi:10.1002/jmv.27487</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>